| Trial ID: | L1787 |
| Source ID: | NCT00636766
|
| Associated Drug: |
Atorvastatin
|
| Title: |
Diagnosis and Therapy of Vulnerable Atherosclerotic Plaque
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Carotid Atherosclerosis|Stroke|Type 2 Diabetes|Metabolic Syndrome
|
| Interventions: |
DRUG: atorvastatin|DRUG: rimonabant|DRUG: rosiglitazone|DRUG: metformin
|
| Outcome Measures: |
Primary: Ultrasound and immunohistochemical parameters of plaque stability; novel cardiovascular risk factors, 3 years | Secondary: Long-term cardiovascular outcomes, 3 years
|
| Sponsor/Collaborators: |
Sponsor: Aristotle University Of Thessaloniki
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
300
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: NONE|Primary Purpose:
|
| Start Date: |
2005-09
|
| Completion Date: |
2009-01
|
| Results First Posted: |
|
| Last Update Posted: |
2012-11-02
|
| Locations: |
General Hospital of Thessaloniki "Hippokratio", Thessaloniki, Greece
|
| URL: |
https://clinicaltrials.gov/show/NCT00636766
|
